News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
626,027 Results
Type
Article (49107)
Company Profile (223)
Press Release (576693)
Multimedia
Podcasts (124)
Webinars (22)
Section
Business (165207)
Career Advice (2498)
Deals (29914)
Drug Delivery (144)
Drug Development (76750)
Employer Resources (145)
FDA (14826)
Job Trends (13426)
News (292515)
Policy (29328)
Tag
2027 BioCapital Elite (1)
2027 BioCapital Standard (1)
2027 BioMidwest Elite (2)
2027 BioMidwest Standard (1)
2027 Bio NC Standard (2)
2027 Biotech Bay Elite (1)
2027 Biotech Bay Standard (1)
2027 Biotech Beach Elite (2)
2027 Biotech Beach Standard (1)
2027 Genetown Elite (3)
2027 Genetown Standard (2)
2027 Pharm Country Elite (2)
2027 Pharm Country Premier (1)
2027 Pharm Country Standard (6)
Academia (2816)
Academic (1)
Accelerated approval (54)
ADA (49)
Adcomms (38)
Allergies (189)
Alliances (42722)
ALS (230)
Alzheimer's disease (1879)
Antibody-drug conjugate (ADC) (524)
Approvals (15244)
Artificial intelligence (750)
ASCO (345)
Autoimmune disease (340)
Automation (60)
Bankruptcy (322)
Best Places to Work (10967)
BIO (62)
BIOSECURE Act (22)
Biosimilars (229)
Biotechnology (159)
Bladder cancer (204)
Brain cancer (74)
Breast cancer (791)
Cancer (6267)
Cardiovascular disease (524)
Career advice (2132)
Career pathing (45)
CAR-T (366)
CDC (63)
Celiac Disease (3)
Cell therapy (985)
Cervical cancer (49)
Clinical research (67333)
Collaboration (2165)
Commercialization (1)
Company closure (7)
Compensation (1033)
Complete response letters (91)
COVID-19 (2737)
CRISPR (122)
C-suite (1279)
Cystic fibrosis (156)
Data (8529)
Decentralized trials (3)
Denatured (33)
Depression (186)
Dermatology (92)
Diabetes (674)
Diagnostics (6702)
Digital health (55)
Diversity (12)
Diversity, equity & inclusion (40)
Drug discovery (362)
Drug pricing (222)
Drug shortages (33)
Duchenne muscular dystrophy (311)
Earnings (64151)
Editorial (72)
Employer branding (19)
Employer resources (138)
Events (92143)
Executive appointments (1156)
FDA (18697)
Fibrodysplasia Ossificans Progressiva (9)
Friedreich's ataxia (22)
Frontotemporal dementia (34)
Funding (1757)
Gene editing (265)
Generative AI (66)
Gene therapy (801)
GLP-1 (1179)
Government (4719)
Grass and pollen (7)
Guidances (418)
Healthcare (17811)
Hematology (175)
HIV (91)
Huntington's disease (61)
Idiopathic pulmonary fibrosis (1)
IgA nephropathy (111)
Immunology and inflammation (325)
Immuno-oncology (105)
Indications (211)
Infectious disease (3103)
Inflammatory bowel disease (229)
Inflation Reduction Act (14)
Influenza (138)
Intellectual property (305)
Interviews (535)
IPO (13782)
IRA (54)
Job creations (2802)
Job search strategy (1709)
JPM (62)
Kidney cancer (22)
Labor market (82)
Layoffs (564)
Leadership (50)
Legal (6324)
Liver cancer (105)
Longevity (34)
Lung cancer (849)
Lymphoma (460)
Machine learning (62)
Management (53)
Manufacturing (1075)
Marketing (3)
MASH (229)
Medical affairs (1)
Medical device (11686)
Medtech (11827)
Mergers & acquisitions (17361)
Metabolic disorders (1714)
mRNA (239)
Multiple sclerosis (200)
NASH (24)
Neurodegenerative disease (481)
Neuropsychiatric disorders (121)
Neuroscience (3547)
Neurotech (1)
NextGen: Class of 2026 (5995)
Non-profit (4334)
Now hiring (72)
Obesity (798)
Opinion (333)
Ovarian cancer (233)
Pain (271)
Pancreatic cancer (352)
Parkinson's disease (393)
Partnered (33)
Patents (615)
Patient recruitment (755)
Peanut (61)
People (56597)
Pharmaceutical (42)
Pharmacy benefit managers (26)
Phase 1 (20770)
Phase 2 (29560)
Phase 3 (22487)
Pipeline (9610)
Policy (353)
Postmarket research (2549)
Preclinical (8741)
Press Release (60)
Prostate cancer (333)
Psychedelics (69)
Radiopharmaceuticals (326)
Rare diseases (1209)
Real estate (4703)
Recruiting (62)
Regulatory (24045)
Reports (33)
Research institute (2450)
Resumes & cover letters (364)
Rett syndrome (45)
RNA editing (30)
RSV (83)
Schizophrenia (188)
Series A (305)
Series B (224)
Service/supplier (3)
Sickle cell disease (124)
Special edition (25)
Spinal muscular atrophy (172)
Sponsored (46)
Startups (3152)
State (2)
Stomach cancer (19)
Supply chain (127)
Tariffs (86)
The Weekly (89)
Vaccines (1131)
Venture capital (124)
Weight loss (532)
Women's health (122)
Worklife (21)
Date
Today (56)
Last 7 days (454)
Last 30 days (2252)
Last 365 days (28722)
2026 (15192)
2025 (28601)
2024 (32807)
2023 (36901)
2022 (47622)
2021 (51178)
2020 (49595)
2019 (42805)
2018 (32469)
2017 (29301)
2016 (28026)
2015 (32436)
2014 (24684)
2013 (20497)
2012 (21846)
2011 (22592)
2010 (20098)
Location
Africa (816)
Alabama (92)
Alaska (5)
Arizona (275)
Arkansas (13)
Asia (38489)
Australia (7654)
California (12538)
Canada (3727)
China (1476)
Colorado (525)
Connecticut (538)
Delaware (415)
Europe (87521)
Florida (2018)
Georgia (396)
Hawaii (3)
Idaho (60)
Illinois (1073)
India (94)
Indiana (595)
Iowa (21)
Japan (583)
Kansas (127)
Kentucky (45)
Louisiana (55)
Maine (73)
Maryland (1546)
Massachusetts (9089)
Michigan (335)
Minnesota (597)
Mississippi (6)
Missouri (150)
Montana (29)
Nebraska (27)
Nevada (139)
New Hampshire (82)
New Jersey (3516)
New Mexico (28)
New York (3394)
North Carolina (1610)
North Dakota (9)
Northern California (6304)
Ohio (364)
Oklahoma (16)
Oregon (36)
Pennsylvania (2569)
Puerto Rico (30)
Rhode Island (46)
South America (1094)
South Carolina (83)
South Dakota (2)
Southern California (4979)
Tennessee (198)
Texas (2073)
United States (44979)
Utah (391)
Vermont (2)
Virginia (338)
Washington D.C. (75)
Washington State (1035)
West Virginia (4)
Wisconsin (122)
Wyoming (2)
626,027 Results for "aevi genomic medicine formerly known as medgenics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
BreezeBio (Formerly GenEdit) Announces Series B Financing to Advance Internal Pipeline of Precision Genetic Medicines
February 25, 2026
·
4 min read
Press Releases
The African Medicines Agency (AMA) and U.S. Pharmacopeia (USP) Sign Memorandum of Understanding to Advance Access to Safe, Effective & Quality-Assured Medicines Across Africa
The agreement establishes a framework for cooperation between the African Medicines Agency (AMA) and the U.S. Pharmacopeia to strengthen regulatory systems, enhance capacity building, and improve access to quality-assured medical products across Africa.
April 29, 2026
·
3 min read
Press Releases
Genomic Testing Cooperative to Exhibit and Present Research at 2026 ASCO Annual Meeting
May 28, 2026
·
4 min read
Press Releases
KROMATID to Present Breakthrough Genomic Integrity Benchmarking at ASGCT 2026, Powering the World’s First Genomic Intelligence Platform
April 30, 2026
·
2 min read
Press Releases
Tempus Announces the Upcoming Clinical Availability of Its First Whole-Genome Sequencing Assay, xH
June 2, 2026
·
5 min read
Press Releases
Mighty Therapeutics, Formerly Stealth BioTherapeutics, Announces New Name Honoring the Mitochondrial Disease Community
June 16, 2026
·
6 min read
Press Releases
10x Genomics Acquires Proteintech Genomics, a Division Within Proteintech Group
June 9, 2026
·
6 min read
Press Releases
Foundation Medicine Showcases Innovation at 2026 ASCO® Annual Meeting
May 22, 2026
·
6 min read
Press Releases
Metabolon Delivers Large-Scale Metabolomics Dataset to Genomics England’s 100,000 Genomes Project to Advance Rare Disease Research
June 24, 2026
·
5 min read
Press Releases
REPATHA® CUTS RISK OF FIRST MAJOR CARDIOVASCULAR EVENTS BY 31% IN HIGH-RISK PATIENTS WITHOUT KNOWN SIGNIFICANT ATHEROSCLEROSIS
March 30, 2026
·
19 min read
1 of 62,603
Next
